Jamshed Dalal
Overview
Explore the profile of Jamshed Dalal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tada H, Yeo K, Li J, Tan K, Ako J, Krittayaphong R, et al.
JACC Asia
. 2022 Nov;
1(3):294-302.
PMID: 36341217
Approximately one-half of the phenotypic susceptibility to atherosclerotic cardiovascular disease (ASCVD) has a genetic basis. Although individual allelic variants generally impart a small effect on risk for ASCVD, an emerging...
12.
Dalal J, Poncha F, Bansal S, Das A, Gupta P, Ghosh D, et al.
Cureus
. 2022 Jun;
14(5):e25102.
PMID: 35733454
Atrial fibrillation (AF), the most prevalent cardiac arrhythmia encountered in clinical practice, is linked with substantial morbidity and mortality due to accompanying risk of stroke and thromboembolism. Patients with AF...
13.
Dalal J, Sawhney J, Jayagopal P, Hazra P, Khan M, Gaurav K, et al.
Int J Hypertens
. 2022 Mar;
2022:6868143.
PMID: 35251710
Introduction: Calcium channel blockers have pedal edema as one of the confining factors of treatment. A real-world study may help evident reality of the situation in regular Indian clinical practice....
14.
Dalal J, Mohan J, Sathe S, Kumar A, Hiremath J, Khan M, et al.
Cardiol Ther
. 2022 Feb;
11(1):129-141.
PMID: 35138595
Introduction: Fondaparinux is a low molecular weight heparin anticoagulant used to manage the full spectrum of acute coronary syndrome (ACS) patients and has proved its efficacy and safety in multiple...
15.
Ram C, Dalal J, Kahali D, Mohanan P, Das M, Guha S, et al.
Am J Cardiol
. 2022 Jan;
167:62-67.
PMID: 35034692
Uncontrolled hypertension is an important cardiovascular risk factor and therefore requires effective approaches to patient management. This study assessed approaches to the management of patients with Stage 2 hypertension by...
16.
Koh N, Ference B, Nicholls S, Navar A, Chew D, Kostner K, et al.
Eur Cardiol
. 2022 Jan;
16:e54.
PMID: 35024056
The prevalence of dyslipidaemia has been increasing in the Asia-Pacific region and this is attributed to dietary changes and decreasing physical activity. While there has been substantial progress in dyslipidaemia...
17.
Tan J, Chew D, Tsui K, Tan D, Duplyakov D, Hammoudeh A, et al.
Eur Cardiol
. 2021 Nov;
16:e43.
PMID: 34815751
Advanced age, diabetes, and chronic kidney disease not only increase the risk for ischaemic events in chronic coronary syndromes (CCS) but also confer a high bleeding risk during antiplatelet therapy....
18.
Khan M, Pandit S, Dalal J, Bansal S, Iyengar S, Karnik R, et al.
J Assoc Physicians India
. 2021 Sep;
69(6):11-12.
PMID: 34472787
Background: The present study intended to estimate the comorbidities and risk factors among patients with hypertension in India. Further, the current practice of hypertension management was evaluated and the choice...
19.
Li J, Yeo K, Tan K, Ako J, Krittayaphong R, Tan R, et al.
Am J Prev Cardiol
. 2021 Jul;
4:100096.
PMID: 34327472
With the global spread of abdominal obesity, cardiovascular disease continues to spread to all countries of the world. Given the large population, the challenges presented by cardiometabolic risk in the...
20.
Chong D, Andreotti F, Verhamme P, Dalal J, Uaprasert N, Wang C, et al.
Eur Cardiol
. 2021 Jun;
16:e23.
PMID: 34135993
The disease burden of AF is greater in Asia-Pacific than other areas of the world. Direct oral anticoagulants (DOACs) have emerged as effective alternatives to vitamin K antagonists (VKA) for...